Abstract: In some embodiments, a wearable cardioverter defibrillator (“WCD”) system comprises a support structure configured to be worn by a patient, a power source, an energy storage module configured to be coupled to the support structure, to be charged from the power source and to store an electrical charge, a discharge circuit coupled to the energy storage module, the discharge circuit controllable to discharge the electrical charge so as to cause a shock to be delivered to the patient, a measurement circuit configured to render a physiological input from a patient physiological signal, a user interface configured to output one or more human-perceptible indications, and a processor.
Type:
Grant
Filed:
September 12, 2019
Date of Patent:
March 22, 2022
Assignee:
West Affum Holdings Corp.
Inventors:
Phillip D. Foshee, Jr., David P. Finch, Laura M. Gustavson, Nikolai Korsun, Joseph L. Sullivan, Gregory T. Kavounas
Abstract: Systems and methods for vibration-based communication disclosed. In one embodiment, a system includes: a motion sensor configured to detect vibrations from a remote device; a processor coupled to the motion sensor and configured to: receive signals from the motion sensor; and activate a network connection based on signals from the motion sensor.
Abstract: An implantable medical device capable of sensing cardiac signals and delivering cardiac electrical stimulation therapies is enabled to detect a short circuit event. A signal is sensed by a sensing module coupled to electrodes. A controller detects a short circuit event in response to a slope of the sensed signal exceeding a short circuit threshold.
Type:
Grant
Filed:
May 10, 2019
Date of Patent:
March 22, 2022
Assignee:
Medtronic, Inc.
Inventors:
Bruce D. Gunderson, Marshall S. Stanton
Abstract: An implantable neurostimulator (INS) and method of use, the INS including an electrical lead having formed thereon at least a pair of bi-polar electrodes, wherein the electrical lead is configured for placement of the pair of bi-polar electrodes proximate protrusor muscles of a patient, a pulse generator electrically connected to the electrical lead and configured to deliver electrical energy to the pair of bi-polar electrodes, the pulse generator having mounted therein a sensor and a control circuit, and the sensor is configured to generate signals representative of an orientation of the pulse generator and communicate the signals to the control circuit and the control circuit is configured to determine the orientation of the pulse generator and deliver electrical energy to the bi-polar electrodes when the determined orientation correlates to a pre-determined orientation.
Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
Type:
Grant
Filed:
July 26, 2019
Date of Patent:
March 1, 2022
Assignee:
Medtronic, Inc.
Inventors:
Shantanu Sarkar, Michael Hudziak, Jerry Reiland, Erin Reisfeld
Abstract: Portable transdermal electrical stimulation (TES) applicators for modifying a subject's cognitive state by applying stimulation to the subject's skin. One or more electrode may be on the subject's mastoid, and/or on or near the back of the subject's neck. The portable applicators are configured and adapted to be lightweight and may be wearable, and to deliver a high-intensity TES able to evoke or enhance a predetermined cognitive effect to stimulate either the trigeminal, facial and/or cervical plexus. These TES applicators may include a pair of electrodes and a TES control module comprising a processor, a timer and a waveform generator.
Type:
Grant
Filed:
May 20, 2019
Date of Patent:
February 1, 2022
Assignee:
Thync Global, Inc.
Inventors:
Jonathan D. Charlesworth, Sumon K. Pal, William J. Tyler, Daniel Z. Wetmore, Isy Goldwasser, Alyssa M. Boasso, Hailey M. Mortimore, Rafal Piersiak
Abstract: A device includes a handle, an expandable structure including a plurality of splines extending from a proximal hub to a distal hub, a first electrode on a first spline of the plurality of splines, an outer tube extending from the handle to the proximal hub, and a shaft extending through the outer tube from the handle to the distal hub. The expandable structure has a collapsed state and a self-expanded state. The handle is configured to retract the shaft. Retracting the shaft may expand the expandable structure outward of the self-expanded state.
Type:
Grant
Filed:
October 21, 2019
Date of Patent:
January 25, 2022
Assignee:
Cardionomic, Inc.
Inventors:
Steven C. Christian, Steven L. Waldhauser, Mark R. Christianson
Abstract: A capsule includes a tubular body with, at its proximal end, a coupling member adapted to cooperate with a conjugated coupling member mounted at the distal end of a catheter of the implantation tool, for the transmission of a torque for the rotational driving of the capsule by the catheter. The coupling member of the tool includes a dihedral-shaped imprint, with two diverging arms in a V-arrangement, and the capsule coupling member includes a convex surface adapted to frictionally and slidingly urge against the diverging arms of the V-shape.
Abstract: Methods and systems treat abnormal cardiac electrical activity employing a probe having first and second ablation electrodes disposed on a distal portion of the probe and a sensing electrode disposed between the first and second ablation electrodes, bringing the probe into contact with cardiac tissue, and applying energy through the first and second ablation electrodes to ablate target tissue along an ablation path, monitoring cardiac electrical activity using the sensing electrode to detect the cardiac electrical activity. After making an observation that the cardiac electrical activity is no longer detectable by the sensing electrode, energy application is terminated.
Type:
Grant
Filed:
September 19, 2019
Date of Patent:
January 4, 2022
Assignee:
Biosense Webster (Israel) Ltd.
Inventors:
Assaf Govari, Andres Claudio Altmann, Yaron Ephrath
Abstract: Apparatus is provided for use with a medical implant having a receiving coil. A flexible housing to be placed against skin of a subject includes a flexible transmitting coil and control circuitry for driving a current through the transmitting coil to induce a current in the receiving coil. A sensor coupled to the circuitry determines divergence of a resonance frequency of the transmitting coil when flexed from a nominal resonance frequency of the transmitting coil, occurring in the absence of any forces applied to the transmitting coil. One or more electrical components coupled to the circuitry tune the resonance frequency of the transmitting coil. A switch is coupled to each of the electrical components, the switches including transistors having capacitances that depend on the voltage applied to each switch. The circuitry applies a voltage of 30-300 volts to each switch. Other applications are also described.
Type:
Grant
Filed:
January 8, 2020
Date of Patent:
January 4, 2022
Assignee:
BLUEWIND MEDICAL LTD.
Inventors:
Gur Oron, Anton Plotkin, Eran Benjamin, Alexander Firtel, Amiel Greenberg, Yigal Elisha
Abstract: Systems and methods for ambulatory detection of medical events such as cardiac arrhythmia are described herein. An embodiment of an arrhythmia detection system may include a detection criterion circuit that determines a patient-specific detection criterion using a baseline cardiac characteristic when the patient is free of cardiac arrhythmias. The detection criterion circuit generates a patient-specific threshold of a signal metric by adjusting a population-based threshold of the signal metric, where the manner and the amount of adjustment is based on information about patient baseline cardiac characteristic. The arrhythmia detection system detects an arrhythmia episode using a physiologic signal sensed from the patient and the patient-specific arrhythmia detection threshold.
Type:
Grant
Filed:
April 18, 2019
Date of Patent:
December 21, 2021
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Sunipa Saha, David L. Perschbacher, Deepa Mahajan
Abstract: In some examples, electrical stimulation is delivered to a patient such that selective termination of the stimulation causes a therapeutic effect in the patient after termination of the electrical stimulation to the patient. The electrical stimulation may be insufficient to produce a desired therapeutic effect in the patient during stimulation, but sufficient to induce a post-stimulation desired therapeutic effect following termination of the stimulation. In some examples, the electrical stimulation may be sub-threshold electrical stimulation. In some examples, the desired therapeutic effect may alleviate bladder dysfunction, bowel dysfunction, or other disorders. The stimulation may be selectively terminated in response to one or more therapy trigger events to induce the post-stimulation therapeutic effect.
Abstract: The present invention provides a closed-loop system for real-time control of epidural and/or subdural electrical stimulation comprising: means for applying to a subject neuromodulation with adjustable stimulation parameters, said means being operatively connected with a real-time monitoring component comprising sensors continuously acquiring feedback signals from said subject, said signals being neural signals and/or signals providing features of motion of said subject, said system being operatively connected with a signal processing device receiving said feedback signals and operating real-time automatic control algorithms, said signal processing device being operatively connected with said means and providing said means with new stimulation parameters, with minimum delay. The system of the invention improves consistency of walking in a subject with a neuromotor impairment.
Type:
Grant
Filed:
March 4, 2019
Date of Patent:
December 21, 2021
Assignee:
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
Inventors:
Gregoire Courtine, Nikolaus Wenger, Eduardo Martin Moraud, Silvestro Micera, Marco Bonizzato
Abstract: Apparatus and methods are described including a left-ventricular assist device that includes a tube configured to traverse a subject's aortic valve, with a distal portion of the tube disposed within the subject's left ventricle. A frame is disposed within the distal portion of the tube. A pump disposed within the frame pumps blood through the tube. A distal-tip element defines a straight proximal portion that defines a longitudinal axis, and a curved distal portion that is shaped such as to curve in a first direction with respect to the longitudinal axis before passing through an inflection point and curving in a second direction with respect to the longitudinal axis, such that the curved distal portion defines a bulge on one side of the longitudinal axis. Other applications are also described.
Type:
Grant
Filed:
January 23, 2020
Date of Patent:
December 7, 2021
Assignee:
MAGENTA MEDICAL LTD.
Inventors:
Yosi Tuval, Zev Sohn, Ehud Schwammenthal, Gad Lubinsky, Victor Troshin, Shaul Jacob Leisner Mustacchi, Yinnon Elisha, Yuri Sudin, Hagit Zemer Harel, Avi Rozenfeld
Abstract: An apparatus includes multiple first reservoirs and multiple second reservoirs joined with a substrate. Selected ones of the multiple first reservoirs include a reducing agent, and first reservoir surfaces of selected ones of the multiple first reservoirs are proximate to a first substrate surface. Selected ones of the multiple second reservoirs include an oxidizing agent, and second reservoir surfaces of selected ones of the multiple second reservoirs are proximate to the first substrate surface.
Abstract: Systems and methods for generating blood flow with a pump incorporating linear bearing technology are provided. The pump may include an actuator assembly, a moving assembly, and a linear hydrodynamic or thin-film bearing positioned within a housing. The moving assembly may include at least one magnet and the actuator assembly may include a magnetic assembly for selectively generating a magnetic field to cause linear reciprocating movement of the moving assembly with respect to the actuator assembly. The linear hydrodynamic or thin-film bearing may include a bearing portion on the moving assembly that is in fluid communication with a bearing portion on the actuator assembly or pump housing. The system may involve an implantable pump, an extracorporeal battery and a controller coupled to the implantable pump. The implantable pump may be suitable for use as a left ventricular assist device (LVAD).
Type:
Grant
Filed:
March 5, 2021
Date of Patent:
December 7, 2021
Assignee:
CorWave SA
Inventors:
Trevor Snyder, Carl N. Botterbusch, Petrus Le Blanc, Bastien Wittig
Abstract: A device for conveying power from a location external to a subject to a location within the subject may include a flexible carrier and an adhesive on a first side of the carrier. A coil of electrically conductive material may be associated with the flexible carrier. A mechanical connector may be associated with the carrier opposite the adhesive, wherein the mechanical connector is configured to retain a housing and permit the housing to rotate relative to the flexible carrier. At least one electrical portion may be associated with the carrier in a manner permitting electrical connection to be maintained between the flexible carrier and the housing as the housing is rotated.
Abstract: Devices and methods for improving device therapy such as cardiac resynchronization therapy by determining a value for a device parameter are described. An ambulatory medical device (AMD) can include a sensor circuit to sense a physiological signal and generate two or more signal metrics, and detect an event of worsening cardiac condition using the two or more signal metrics. In response to the detection of worsening cardiac condition, the AMD can determine, for a stimulator, a value of at least one stimulation parameter based on temporal responses of two or more signal metrics. The temporal responses include near-term and long-term responses to the stimulation. The AMD can program the stimulator with the determined parameter value, and generate stimulation according to the determined parameter value to stimulate target tissue.
Type:
Grant
Filed:
May 30, 2019
Date of Patent:
November 16, 2021
Assignee:
Cardiac Pacemakers, Inc.
Inventors:
Qi An, Julie A. Thompson, Yinghong Yu, Yi Zhang, Pramodsingh Hirasingh Thakur
Abstract: A system and method for detecting and verifying bradycardia/asystole episodes includes sensing an electrogram (EGM) signal. The EGM signal is compared to a primary threshold to sense events in the EGM signal, and at least one of a bradycardia or an asystole is detected based on the comparison. In response to detecting at least one of a bradycardia or an asystole, the EGM signal is compared to a secondary threshold to sense events under-sensed by the primary threshold. The validity of the bradycardia or the asystole is determined based on the detected under-sensed events.
Type:
Grant
Filed:
May 18, 2021
Date of Patent:
November 16, 2021
Assignee:
Medtronic, Inc.
Inventors:
Shantanu Sarkar, Michael L. Hudziak, Jerry D. Reiland, Erin N. Reisfeld